Overall rank by patents
#659
Across all tracked assignees
USPTO PatentsView assignee record - 681 granted patents across 6 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01H (NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES).
The verdict
M.s. holds 681 US patents across 6 technology areas, rank #659 of 50,000 tracked assignees.
M.s. Technologies, L.l.c. has been granted 681 US utility patents between 2017 and 2025, placing M.s. Technologies, L.l.c. at rank #659 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.5 claims per patent with primary concentration in A01H (NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES). As a US Corporation, M.s. Technologies, L.l.c. is one of the more focused assignees in the PatentsView dataset. By volume, M.s. sits between The Brigham And Women's Hospital, Inc. (685 patents, rank #655) and Viasat, Inc. (677 patents, rank #663) - the closest US assignees by grant volume. The composite Innovation Score of 48.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 598 grants, compared with 83 in the 2015–2019 window, a +620% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. M.s. Technologies, L.l.c.'s 19.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark M.s. Technologies, L.l.c. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
The Brigham and Women's Hospital, Inc.
685 patents
Yale University
685 patents
TIANMA MICROELECTRONICS CO., LTD.
684 patents
BAYER HEALTHCARE LLC
681 patents
M.S. Technologies, L.L.C.
681 patents
TOPCON CORPORATION
680 patents
SHINKO ELECTRIC INDUSTRIES CO., LTD.
678 patents
Kone Corporation
677 patents
VIASAT, INC.
677 patents
What this shows M.s. holds 681 patents at rank #659, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #659 in granted patent volume.
Other assignees with the most granted patents in Ms's primary technology class.
M.s.'s Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
48 Top 17% higher than 83% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 0.3% |
| 2019 | 81 | 11.9% |
| 2020 | 75 | 11.0% |
| 2021 | 169 | 24.8% |
| 2022 | 76 | 11.2% |
| 2023 | 105 | 15.4% |
| 2024 | 71 | 10.4% |
| 2025 | 102 | 15.0% |
Top 6 of 6 technology areas
Overall rank by patents
#659
Across all tracked assignees
48.1 out of 100
How to use this portfolio
M.s.'s 681 grants land it in the top 17% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.